Latvia - Latvi - Zāļu valsts aģentūra

g.l. pharma gmbh, austria - sunitinibs - kapsula, cietā - 50 mg

Latvia - Latvi - Zāļu valsts aģentūra

zentiva, k.s., czech republic - sunitinibs - kapsula, cietā - 12,5 mg

Latvia - Latvi - Zāļu valsts aģentūra

zentiva, k.s., czech republic - sunitinibs - kapsula, cietā - 50 mg

Uni Eropa - Latvi - EMA (European Medicines Agency)

accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiski līdzekļi - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.

Latvia - Latvi - Zāļu valsts aģentūra

krka, d.d., novo mesto, slovenia - sunitinibs - kapsula, cietā - 25 mg

Latvia - Latvi - Zāļu valsts aģentūra

krka, d.d., novo mesto, slovenia - sunitinibs - kapsula, cietā - 50 mg

Latvia - Latvi - Zāļu valsts aģentūra

norameda uab, lithuania - sunitinibs - kapsula, cietā - 12,5 mg

Latvia - Latvi - Zāļu valsts aģentūra

norameda uab, lithuania - sunitinibs - kapsula, cietā - 50 mg

Latvia - Latvi - Zāļu valsts aģentūra

sandoz d.d., slovenia - sorafenibs - apvalkotā tablete - 400 mg

Latvia - Latvi - Zāļu valsts aģentūra

egis pharmaceuticals plc, hungary - sunitinibs - kapsula, cietā - 12,5 mg